Invrix.com

Financial Statement Analysis Industry Analysis News Analysis

Login Register

Analysis Tools

Financial Trends Company Comparisons Profitability Radar Industry Leaderboard

User

Login Register

Home
/
Biotechnology: Biological Products (No Diagnostic Substances)
/
EDIT

Editas Medicine(Edit) Financials: Compared To Industry Average, Plus Other Key Ratios

Report Profitability Growth Liquidity Solvency Valuation

Valuation Trend (Last 5 Years)

Top 20 by ratio

IMCR - Immunocore plc
HUMA - Humacyte
SGMO - Sangamo Therapeutics
INAB - IN8bio
CVM - Cel-Sci
OTLK - Outlook Therapeutics
ARMP - Armata Pharmaceuticals
SRZNW - Surrozen
EXEL - Exelixis
ABOS - Acumen Pharmaceuticals
ALVO - Alvotech Ordinary Shares
QNCX - Quince Therapeutics
BNTX - BioNTech SE American Depositary Share
MRNA - Moderna
CSBR - Champions Oncology
GLUE - Monte Rosa Therapeutics
RVMD - Revolution Medicines
FATE - Fate Therapeutics
KLTOW - Klotho Neurosciences
CRSP - CRISPR Therapeutics AG Common Shares

© 2025 Invrix. All rights reserved.

About Us Contact Privacy Policy Terms of Service